The global wound closure devices market size was valued at USD 13.23 billion in 2018 and is expected to exhibit a CAGR of 7.1% over the forecast period. The demand for wound closure devices is on a rise owing to the prevalence of chronic wounds, increasing cases of accidents, and the rising number of surgeries. Rising incidence of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers are anticipated to spur the demand for wound closure devices over the forecast period.
For instance, as per studies conducted by B. Braun Melsungen AG, around 2.0% to 10.0% of people affected with diabetes suffer from diabetic foot ulcers. In addition, as per the American College of Physicians, in 2017, the global annual incidence of diabetic foot ulcers was around 6.3% and the lifetime incidence of foot ulcers in patients suffering from diabetes ranges from 19.0% to 34.0%. Furthermore, as per the National Center for Biotechnology Information (NCBI), in 2017, the prevalence rate of diabetic foot ulcers in North America was 13.0% (highest), 5.5% in Asia, 7.2% in Africa, 5.1% in Europe, 1.5% in Australia, 16.6% in Belgium, 14.8% in Canada, and 13.0% in the U.S. Wound closure devices such as sutures, staples, and mechanical wound closure systems are used for the treatment of such chronic wounds.
The incidence rate of pressure ulcers is rising owing to the rapidly aging population and an increase in the incidence of disabilities across the globe. In the U.S., around USD 11.00 billion is spent every year on the treatment of pressure ulcers, as per NCBI. Furthermore, the prevalence rate of pressure ulcers in nursing home patients is around 11.0% per year. Similarly, the prevalence rate of venous leg ulcers ranges from 0.18% to 1.0%, as per NCBI. Venous leg ulcers are the most advanced form of chronic venous disorders and the recurrence rate of these ulcers is more than 70.0%. Such a high incidence of chronic wounds is anticipated to propel the demand for wound closure devices over the forecast period.
Furthermore, in the recent past, there has been a rise in the number of surgical procedures across the globe. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed. The incidence of infectious and non-communicable diseases has increased over the past few decades. These factors are likely to accelerate market growth during the forecast period.
Key players are launching technologically advanced products to ease surgical procedures. For instance, in November 2015, Medtronic launched the VenaSeal (TM) closure system in the U.S. This system is the only non-sclerosant, non-tumescent, and non-thermal product used in the treatment of symptomatic venous reflux. It uses proprietary medical adhesive to close lower extremities’ superficial veins in minimally invasive procedures. The system is currently available in the U.S., Europe, UAE, Hong Kong, New Zealand, Canada, Chile, Australia, and South Africa.
On the basis of product, the market has been segmented into adhesives, staples, sutures, strips, sealants, and mechanical wound closure devices. Sutures held the dominant market share in 2018 owing to the rising number of accidents across the globe. Sutures comprise a needle with a thread attached to it and it comes in various shapes, sizes, and a wide variety of thread materials. Sutures market has been further segmented into absorbable and non-absorbable. The absorbable sutures market is anticipated to witness the fastest growth over the forecast period as they are more convenient and easy-to-use as compared to the non-absorbable sutures.
The staples segment is anticipated to witness the fastest growth over the forecast period. The usage of staples is on a rise as stapling is more convenient and faster than suturing. Surgical staples are usually made of titanium or stainless steel. Staple lines can be circular, straight, or curved. However, unlike sutures, staples are not absorbable, and thus requires constant care. This factor might restrain segment growth.
The wound closure devices market has been segmented into chronic and acute. The acute segment held the dominant market share in 2018 owing to the rising number of surgeries and burn cases, globally. For instance, as per WHO, in South Africa, approximately USD 26.00 million is spent every year on the care of burns resulting from kerosene cooking stove incidents. Such acute injuries require quick closure using advanced medical devices. The major reasons leading to the high prevalence of burn cases include poverty, lack of proper safety measures, use of kerosene for non-electric domestic appliances, alcohol abuse, and smoking.
Chronic wounds include diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Increasing cases of chronic diseases, especially diabetes, and rising geriatric population across the globe are the major factors driving the segment. For instance, as per the United States Census Bureau, the number of people aged 65 and above grew by 1.6 million from 2014 to 2015. Increasing geriatric population susceptible to chronic diseases and injuries is expected to impel the demand for wound closure devices.
End-users of wound closure devices are hospitals, hospitals, clinics, trauma centers, and others. The hospital segment held the largest market share in 2018 due to the rising number of surgeries and increasing cases of road accidents. For instance, as per WHO, around 1.35 million people die every year in road accidents and it costs almost 3.0% of the Gross Domestic Product (GDP) for most of the countries.
The clinic segment is anticipated to witness the fastest growth over the forecast period owing to the increasing demand for reduced hospital stay. As per the American Hospital Association (AHA), approximately 20.0% of Medicare beneficiaries, when discharged from hospitals, return within 30 days for the closure of fresh wounds. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and minimizing expenditure. Hence, policymakers are striving to reduce the stay of patients in hospitals.
The North America market held the dominant share in 2018 owing to the presence of major players in the region and the rising prevalence of chronic wounds. In addition, the increasing number of patients undergoing surgeries and rising awareness about minimally invasive surgeries are also responsible for regional market growth. Key players operating in the North America market include 3M; Johnson & Johnson Services, Inc.; B. Braun Melsungen AG; Medtronic; and Baxter. These companies are investing in R&D to develop medical devices that can expedite the closure of the wound.
The Asia Pacific market is anticipated to witness the fastest growth over the forecast period. The growth of the market is attributable to rising medical tourism in the region. For instance, as per a report on Export Health Services by Directorate-General of Commercial Intelligence and Statistics of India, in 2015-2016, India had 58,300 medical tourists on medical visas. The advent of advanced medical devices that can be used for quick and effective closure of wounds will drive regional growth.
Prominent players in the market include 3M; Johnson & Johnson Services, Inc.; B. Braun Melsungen AG; Medtronic; Baxter; Integra LifeSciences Corporation; and Smith & Nephew. Key players are involved in adopting strategies such as mergers and acquisitions, collaborations, and partnerships to strengthen their position in the market.
For instance, in February 2017, Medtronic launched Signia stapling system, a surgical stapler for minimally invasive surgery. The system provides real-time feedback to surgeons and automated response to real-time data. The Adaptive Firing technology in the device detects tissue variability and automatically adjusts the speed of stapling during minimally invasive procedures. Such product development strategies are anticipated to increase the consumer base of the company, thereby, strengthening its foothold in the market.
Base year for estimation
Actual estimates/Historical data
2015 - 2017
2019 - 2026
Revenue in USD Million and CAGR from 2018 to 2026
North America, Europe, Asia Pacific, Latin America, MEA
U.S., Canada, U.K., Germany, China, Japan, Brazil, Mexico, South Africa, Saudi Arabia
Revenue, company share, competitive landscape, growth factors, trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global wound closure devices market report on the basis of product, wound type, end-use, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Mechanical wound closure devices
Wound Type Outlook (Revenue, USD Million, 2015 - 2026)
End-use Outlook (Revenue, USD Million, 2015 - 2026)
Regional Outlook (Revenue, USD Million, 2015 - 2026)
b. The global wound closure devices market size was estimated at USD 14.10 billion in 2019 and is expected to reach USD 15.05 billion in 2020.
b. The global wound closure devices market is expected to grow at a compound annual growth rate of 7.1% from 2019 to 2026 to reach USD 22.98 billion by 2026.
b. The acute segment held the dominant market share in 2019 with a market share of more than 60.0% owing to the rising number of surgeries and burn cases, globally.
b. Some key players operating in the wound closure devices market include 3M; Johnson & Johnson Services, Inc.; B. Braun Melsungen AG; Medtronic; Baxter; Integra LifeSciences Corporation; and Smith & Nephew.
b. Key factors that are driving the market growth include the prevalence of chronic wounds, increasing cases of accidents, and the rising number of surgeries.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.